Title(s):
Associate Professor of Surgery
Associate Professor of Oncology
Associate Professor of Oncology
Director of Clinical and Translational Research in Thoracic Surgery
Appointment Phone:
443-997-1508
Primary Location:
The Johns Hopkins Hospital
Expertise:
Endsocopic Thoracic Sympathectomy (ETS), Esophageal Cancer, General Surgery, Hyperhidrosis, Lung Cancer, Mesothelioma
Education and Experience
Training
- Johns Hopkins University School of Medicine (Baltimore MD)/ (1991)
Residencies
- The Johns Hopkins Hospital (Baltimore MD)/ Surgery (2000)
Certifications
- Thoracic Surgery, American Board of Thoracic Surgery (2003)
Locations
The Johns Hopkins Hospital
600 N. Wolfe Street
Hospital Main Entrance - Sheikh Zayed Tower
Baltimore, MD 21287
Phone: 410-614-3891
Appointment Phone: 443-997-1508
Fax: 410-614-9428
Location Map
Department / Division
- Surgery
Centers/Institutes
Centers / Institutes
- Esophageal Cancer Program
- Sidney Kimmel Comprehensive Cancer Center
Bio
Biography
Malcolm V. Brock, M.D., a graduate of the Johns Hopkins University School of Medicine, the Johns Hopkins General Surgical residency program and the Johns Hopkins fellowship in Cardiothoracic Surgery, is a specialist in thoracic oncology, and is an Associate Professor of Surgery and Oncology at Johns Hopkins. In additional to clinical thoracic oncology, his clinical interests include surgery for palmar, axillary and pedal hyperhydrosis.
Board-certified in General as well as Thoracic Surgery, Dr Brock is a surgeon who conducts cancer research at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins specializing in bringing innovative basic, bench top research to the clinic and to the bedside. His main research interests are in developing novel molecular biomarkers for solid tumors that can help clinicians diagnose cancer earlier and treat it more effectively. Recently, his laboratory utilized a basic research DNA technique in the clinic to predict patients who will develop recurrent lung cancer even after successful surgery, and to predict patients with esophageal cancer who will be sensitive to certain chemotherapeutic drugs. This work was recently recognized for publication in the New England Journal of Medicine. Dr Brock has published over 70 original research papers, book chapters and review articles, has presented often at national and international conferences, and has been the recipient of research funding from the National Institutes of Health (NIH), the Thoracic Surgery Foundation for Research Excellence, the American College of Surgery Oncology Group as well as the Society of Surgical Oncology.
Board-certified in General as well as Thoracic Surgery, Dr Brock is a surgeon who conducts cancer research at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins specializing in bringing innovative basic, bench top research to the clinic and to the bedside. His main research interests are in developing novel molecular biomarkers for solid tumors that can help clinicians diagnose cancer earlier and treat it more effectively. Recently, his laboratory utilized a basic research DNA technique in the clinic to predict patients who will develop recurrent lung cancer even after successful surgery, and to predict patients with esophageal cancer who will be sensitive to certain chemotherapeutic drugs. This work was recently recognized for publication in the New England Journal of Medicine. Dr Brock has published over 70 original research papers, book chapters and review articles, has presented often at national and international conferences, and has been the recipient of research funding from the National Institutes of Health (NIH), the Thoracic Surgery Foundation for Research Excellence, the American College of Surgery Oncology Group as well as the Society of Surgical Oncology.
Physician Title
Director of Clinical and Translational Research in Thoracic Surgery
Expertise
- Endsocopic Thoracic Sympathectomy (ETS)
- Esophageal Cancer
- General Surgery
- Hyperhidrosis
- Lung Cancer
- Mesothelioma
Research
Research and Publications
Research Summary
Dr. Brock's research has focused primarily on developing and clinically applying molecular biomarkers, namely DNA methylation, to facilitate the early detection, accurate prognosis and specific chemosensitivity of lung and esophageal cancers. Current projects include using DNA methylation as a more accurate molecular indicator of lymph micrometases in a large cohort of lung cancer patients and as a means of predicting sensitivity of esophageal cancer to neoadjuvant chemotherapy based on endoscopic biopsy samples. Dr. Brock actively collaborates with Drs. Stephen Baylin and James Herman in the Division of Tumor Biology in the Cancer Center. Recently, Dr. Brock has received NIH funding to investigate the rising incidence of lung cancer in HIV patients and has begun both a clinical study and a tumor-profiling project in this regard. Finally, the Brock laboratory has developed large relational databases of lung and esophageal patients with matching biological samples to validate biomarker discovery.
Journal Citations
Brock, M.V.; Hooker, C.M.; Engels, E.A.; Moore, R.D.; Gillison, M.L.; Alberg, A.J.; Keruly, J.C.; Yang, S.C.; Heitmiller, R.F.; Baylin, S.B.; Herman, J.G.; Brahmer, J.R. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55.
Chan, C.W.; Crafton, E.; Fan, H.N.; Flook, J.; Yoshimura, K.; Skarica, M.; Brockstedt, D.; Dubensky, T.W.; Stins, M.F.; Lanier, L.L.; Pardoll, D.M.; Housseau, F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med. 2006 Feb;12(2):207-213.
Engels, E.A.; Brock, M.V.; Chen, J.; Hooker, C.M.; Gillison, M.; Moore, R.D. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006 Mar 20;24(9):1383-1388.
Gallia, G.L.; Rand, V.; Siu, I.M.; Eberhart, C.G.; James, C.D.; Marie, S.K.; Oba-Shinjo, S.M.; Carlotti, C.G.; Caballero, O.L.; Simpson, A.J.; Brock, M.V.; Massion, P.P.; Carson, B.S., Sr.; Riggins, G.J. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res. 2006 Oct;4(10):709-714.
Guo, M.; House, M.G.; Akiyama, Y.; Qi, Y.; Capagna, D.; Harmon, J.; Baylin, S.B.; Brock, M.V.; Herman, J.G. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006 Nov 1;119(9):2078-2083.
Guo, M.; Ren, J.; House, M.G.; Qi, Y.; Brock, M.V.; Herman, J.G. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2006 Aug 1;12(15):4515-4522.
Machida, E.O.; Brock, M.V.; Hooker, C.M.; Nakayama, J.; Ishida, A.; Amano, J.; Picchi, M.A.; Belinsky, S.A.; Herman, J.G.; Taniguchi, S.; Baylin, S.B. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. Cancer Res. 2006 Jun 15;66(12):6210-6218.
Montgomery, E.; Mamelak, A.J.; Gibson, M.; Maitra, A.; Sheikh, S.; Amr, S.S.; Yang, S.; Brock, M.; Forastiere, A.; Zhang, S.; Murphy, K.M.; Berg, K.D. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):24-30.
Singh, A.; Misra, V.; Thimmulappa, R.K.; Lee, H.; Ames, S.; Hoque, M.O.; Herman, J.G.; Baylin, S.B.; Sidransky, D.; Gabrielson, E.; Brock, M.V.; Biswal, S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006 Oct;3(10):e420.
Weiss, E.S.; Doty, J.; Brock, M.V.; Halvorson, L.; Yang, S.C. A case of ectopic parathyroid hormone production by a pulmonary neoplasm. J Thorac Cardiovasc Surg. 2006 Apr;131(4):923-924.
Yoshimura, K.; Jain, A.; Allen, H.E.; Laird, L.S.; Chia, C.Y.; Ravi, S.; Brockstedt, D.G.; Giedlin, M.A.; Bahjat, K.S.; Leong, M.L.; Slansky, J.E.; Cook, D.N.; Dubensky, T.W.; Pardoll, D.M.; Schulick, R.D. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Res. 2006 Jan 15;66(2):1096-1104.
Brock, M.V.; Herman, J.G.; Baylin, S.B. Cancer as a manifestation of aberrant chromatin structure. Cancer J. 2007 Jan-Feb;13(1):3-8.
Engel, L.S.; Laden, F.; Andersen, A.; Strickland, P.T.; Blair, A.; Needham, L.L.; Barr, D.B.; Wolff, M.S.; Helzlsouer, K.; Hunter, D.J.; Lan, Q.; Cantor, K.P.; Comstock, G.W.; Brock, J.W.; Bush, D.; Hoover, R.N.; Rothman, N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res. 2007 Jun 1;67(11):5545-5552.
Gibbons, M.C.; Brock, M.; Alberg, A.J.; Glass, T.; LaVeist, T.A.; Baylin, S.; Levine, D.; Fox, C.E. The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research. J Urban Health. 2007 Mar;84(2):198-211.
Goldberg, M.V.; Maris, C.H.; Hipkiss, E.L.; Flies, A.S.; Zhen, L.; Tuder, R.M.; Grosso, J.F.; Harris, T.J.; Getnet, D.; Whartenby, K.A.; Brockstedt, D.G.; Dubensky, T.W., Jr.; Chen, L.; Pardoll, D.M.; Drake, C.G. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood. 2007 Jul 1;110(1):186-192.
Guo, M.; House, M.G.; Suzuki, H.; Ye, Y.; Brock, M.V.; Lu, F.; Liu, Z.; Rustgi, A.K.; Herman, J.G. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. Int J Cancer. 2007 Sep 15;121(6):1219-1226.
Liu, C.; Zhou, S.; Begum, S.; Sidransky, D.; Westra, W.H.; Brock, M.; Califano, J.A. Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. Lung Cancer. 2007 Mar;55(3):303-311.
Madar, I.; Bencherif, B.; Lever, J.; Heitmiller, R.F.; Yang, S.C.; Brock, M.; Brahmer, J.; Ravert, H.; Dannals, R.; Frost, J.J. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med. 2007 Feb;48(2):207-213.
Sherwood, J.T.; Brock, M.V. Lung cancer: new surgical approaches. Respirology. 2007 May;12(3):326-332.
Taube, J.M.; Askin, F.B.; Brock, M.V.; Westra, W. Impact of elastic staining on the staging of peripheral lung cancers. Am J Surg Pathol. 2007 Jun;31(6):953-956.
Brock, M.V.; Hooker, C.M.; Ota-Machida, E.; Han, Y.; Guo, M.; Ames, S.; Glockner, S.; Piantadosi, S.; Gabrielson, E.; Pridham, G.; Pelosky, K.; Belinsky, S.A.; Yang, S.C.; Baylin, S.B.; Herman, J.G. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008 Mar 13;358(11):1118-1128.
Daniels, J.A.; Gibson, M.K.; Xu, L.; Sun, S.; Canto, M.I.; Heath, E.; Wang, J.; Brock, M.; Montgomery, E. Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect. Am J Surg Pathol. 2008 Mar;32(3):473-477.
Forastiere, A.A.; Ang, K.K.; Brizel, D.; Brockstein, B.E.; Burtness, B.A.; Cmelak, A.J.; Colevas, A.D.; Dunphy, F.; Eisele, D.W.; Goepfert, H.; Hicks, W.L., Jr.; Kies, M.S.; Lydiatt, W.M.; Maghami, E.; Martins, R.; McCaffrey, T.; Mittal, B.B.; Pfister, D.G.; Pinto, H.A.; Posner, M.R.; Ridge, J.A.; Samant, S.; Schuller, D.E.; Shah, J.P.; Spencer, S.; Trotti, A., 3rd; Weber, R.S.; Wolf, G.T.; Worden, F. Head and neck cancers. J Natl Compr Canc Netw. 2008 Aug;6(7):646-695.
Guo, M.; Ren, J.; Brock, M.V.; Herman, J.G.; Carraway, H.E. Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. Epigenetics. 2008 Nov;3(6):336-341.
Kleinberg, L.R.; Brock, M.V.; Jagannath, S.B.; Forastiere, A.A. Cancer of the Esophagus. In: Abeloff, M.e.a., editor. 4th Edition ed, Clinical Oncology. New York, NY: Churchill-Livingstone; 2008.
Meguid, R.A.; Brooke, B.S.; Chang, D.C.; Sherwood, J.T.; Brock, M.V.; Yang, S.C. Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg. 2008 Mar;85(3):1015-1024; discussion 1024-1015.
Argiris, A.; Buchanan, A.; Brockstein, B.; Kolesar, J.; Ghebremichael, M.; Pins, M.; Hahn, K.; Axelrod, R.; Forastiere, A. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Cancer. 2009 Oct 1;115(19):4504-4513.
Jiang, T.; Collins, B.J.; Jin, N.; Watkins, D.N.; Brock, M.V.; Matsui, W.; Nelkin, B.D.; Ball, D.W. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res. 2009 Feb 1;69(3):845-854.
Meguid, R.A.; Hooker, C.M.; Taylor, J.T.; Kleinberg, L.R.; Cattaneo, S.M., 2nd; Sussman, M.S.; Yang, S.C.; Heitmiller, R.F.; Forastiere, A.A.; Brock, M.V. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg. 2009 Dec;138(6):1309-1317.
Meguid, R.A.; Weiss, E.S.; Chang, D.C.; Brock, M.V.; Yang, S.C. The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg. 2009 Jan;137(1):23-29.
Tjiang, T.; B.J., C.; Jin, N.; Brock, M.V.; Watkins, D.N.; Matsui, W.; Nelkin, B.D.; Ball, D.W. ASCL1 regulates CD133 and tumor-initiating capacity of SCLC. Cancer Research. 2009 (In Press).
Bailey, V.J.; Keeley, B.P.; Zhang, Y.; Ho, Y.P.; Easwaran, H.; Brock, M.V.; Pelosky, K.L.; Carraway, H.E.; Baylin, S.B.; Herman, J.G.; Wang, T.H. Enzymatic incorporation of multiple dyes for increased sensitivity in QD-FRET sensing for DNA methylation detection. Chembiochem. 2010 Jan 4;11(1):71-74.
Bailey, V.J.; Zhang, Y.; Keeley, B.P.; Yin, C.; Pelosky, K.L.; Brock, M.; Baylin, S.B.; Herman, J.G.; Wang, T.H. Single-tube analysis of DNA methylation with silica superparamagnetic beads. Clin Chem. 2010 Jun;56(6):1022-1025.
Bhattacharya, R.; Kowalski, J.; Larson, A.R.; Brock, M.; Alani, R.M. Id1 promotes tumor cell migration in nonsmall cell lung cancers. J Oncol. 2010;2010:856105.
Brock, M.V.; Bouvet, M. Writing a successful NIH Mentored Career Development Grant (K award): hints for the junior faculty surgeon. Ann Surg. 2010 Jun;251(6):1013-1017
Chiao, E.Y.; Dezube, B.J.; Krown, S.E.; Wachsman, W.; Brock, M.V.; Giordano, T.P.; Mitsuyasu, R.; Pantanowitz, L. Time for oncologists to opt in for routine opt-out HIV testing? JAMA. 2010 Jul 21;304(3):334-339
Liu, K.J.; Brock, M.V.; Shih Ie, M.; Wang, T.H. Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy. J Am Chem Soc. 2010 Apr 28;132(16):5793-5798
Meguid, R.A.; Hooker, C.M.; Harris, J.; Xu, L.; Westra, W.H.; Sherwood, J.T.; Sussman, M.; Cattaneo, S.M., 2nd; Shin, J.; Cox, S.; Christensen, J.; Prints, Y.; Yuan, N.; Zhang, J.; Yang, S.C.; Brock, M.V. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest. 2010 Sep;138(3):500-509.
Tseng, E.E.; Brock, M.V.; Lange, M.S.; Troncoso, J.C.; Blue, M.E.; Lowenstein, C.J.; Johnston, M.V.; Baumgartner, W.A. Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg. 2010 Feb;89(2):440-445
Dr. Brock's research has focused primarily on developing and clinically applying molecular biomarkers, namely DNA methylation, to facilitate the early detection, accurate prognosis and specific chemosensitivity of lung and esophageal cancers. Current projects include using DNA methylation as a more accurate molecular indicator of lymph micrometases in a large cohort of lung cancer patients and as a means of predicting sensitivity of esophageal cancer to neoadjuvant chemotherapy based on endoscopic biopsy samples. Dr. Brock actively collaborates with Drs. Stephen Baylin and James Herman in the Division of Tumor Biology in the Cancer Center. Recently, Dr. Brock has received NIH funding to investigate the rising incidence of lung cancer in HIV patients and has begun both a clinical study and a tumor-profiling project in this regard. Finally, the Brock laboratory has developed large relational databases of lung and esophageal patients with matching biological samples to validate biomarker discovery.
Journal Citations
Brock, M.V.; Hooker, C.M.; Engels, E.A.; Moore, R.D.; Gillison, M.L.; Alberg, A.J.; Keruly, J.C.; Yang, S.C.; Heitmiller, R.F.; Baylin, S.B.; Herman, J.G.; Brahmer, J.R. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55.
Chan, C.W.; Crafton, E.; Fan, H.N.; Flook, J.; Yoshimura, K.; Skarica, M.; Brockstedt, D.; Dubensky, T.W.; Stins, M.F.; Lanier, L.L.; Pardoll, D.M.; Housseau, F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med. 2006 Feb;12(2):207-213.
Engels, E.A.; Brock, M.V.; Chen, J.; Hooker, C.M.; Gillison, M.; Moore, R.D. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006 Mar 20;24(9):1383-1388.
Gallia, G.L.; Rand, V.; Siu, I.M.; Eberhart, C.G.; James, C.D.; Marie, S.K.; Oba-Shinjo, S.M.; Carlotti, C.G.; Caballero, O.L.; Simpson, A.J.; Brock, M.V.; Massion, P.P.; Carson, B.S., Sr.; Riggins, G.J. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res. 2006 Oct;4(10):709-714.
Guo, M.; House, M.G.; Akiyama, Y.; Qi, Y.; Capagna, D.; Harmon, J.; Baylin, S.B.; Brock, M.V.; Herman, J.G. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006 Nov 1;119(9):2078-2083.
Guo, M.; Ren, J.; House, M.G.; Qi, Y.; Brock, M.V.; Herman, J.G. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2006 Aug 1;12(15):4515-4522.
Machida, E.O.; Brock, M.V.; Hooker, C.M.; Nakayama, J.; Ishida, A.; Amano, J.; Picchi, M.A.; Belinsky, S.A.; Herman, J.G.; Taniguchi, S.; Baylin, S.B. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. Cancer Res. 2006 Jun 15;66(12):6210-6218.
Montgomery, E.; Mamelak, A.J.; Gibson, M.; Maitra, A.; Sheikh, S.; Amr, S.S.; Yang, S.; Brock, M.; Forastiere, A.; Zhang, S.; Murphy, K.M.; Berg, K.D. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):24-30.
Singh, A.; Misra, V.; Thimmulappa, R.K.; Lee, H.; Ames, S.; Hoque, M.O.; Herman, J.G.; Baylin, S.B.; Sidransky, D.; Gabrielson, E.; Brock, M.V.; Biswal, S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006 Oct;3(10):e420.
Weiss, E.S.; Doty, J.; Brock, M.V.; Halvorson, L.; Yang, S.C. A case of ectopic parathyroid hormone production by a pulmonary neoplasm. J Thorac Cardiovasc Surg. 2006 Apr;131(4):923-924.
Yoshimura, K.; Jain, A.; Allen, H.E.; Laird, L.S.; Chia, C.Y.; Ravi, S.; Brockstedt, D.G.; Giedlin, M.A.; Bahjat, K.S.; Leong, M.L.; Slansky, J.E.; Cook, D.N.; Dubensky, T.W.; Pardoll, D.M.; Schulick, R.D. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Res. 2006 Jan 15;66(2):1096-1104.
Brock, M.V.; Herman, J.G.; Baylin, S.B. Cancer as a manifestation of aberrant chromatin structure. Cancer J. 2007 Jan-Feb;13(1):3-8.
Engel, L.S.; Laden, F.; Andersen, A.; Strickland, P.T.; Blair, A.; Needham, L.L.; Barr, D.B.; Wolff, M.S.; Helzlsouer, K.; Hunter, D.J.; Lan, Q.; Cantor, K.P.; Comstock, G.W.; Brock, J.W.; Bush, D.; Hoover, R.N.; Rothman, N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res. 2007 Jun 1;67(11):5545-5552.
Gibbons, M.C.; Brock, M.; Alberg, A.J.; Glass, T.; LaVeist, T.A.; Baylin, S.; Levine, D.; Fox, C.E. The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research. J Urban Health. 2007 Mar;84(2):198-211.
Goldberg, M.V.; Maris, C.H.; Hipkiss, E.L.; Flies, A.S.; Zhen, L.; Tuder, R.M.; Grosso, J.F.; Harris, T.J.; Getnet, D.; Whartenby, K.A.; Brockstedt, D.G.; Dubensky, T.W., Jr.; Chen, L.; Pardoll, D.M.; Drake, C.G. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood. 2007 Jul 1;110(1):186-192.
Guo, M.; House, M.G.; Suzuki, H.; Ye, Y.; Brock, M.V.; Lu, F.; Liu, Z.; Rustgi, A.K.; Herman, J.G. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer. Int J Cancer. 2007 Sep 15;121(6):1219-1226.
Liu, C.; Zhou, S.; Begum, S.; Sidransky, D.; Westra, W.H.; Brock, M.; Califano, J.A. Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. Lung Cancer. 2007 Mar;55(3):303-311.
Madar, I.; Bencherif, B.; Lever, J.; Heitmiller, R.F.; Yang, S.C.; Brock, M.; Brahmer, J.; Ravert, H.; Dannals, R.; Frost, J.J. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med. 2007 Feb;48(2):207-213.
Sherwood, J.T.; Brock, M.V. Lung cancer: new surgical approaches. Respirology. 2007 May;12(3):326-332.
Taube, J.M.; Askin, F.B.; Brock, M.V.; Westra, W. Impact of elastic staining on the staging of peripheral lung cancers. Am J Surg Pathol. 2007 Jun;31(6):953-956.
Brock, M.V.; Hooker, C.M.; Ota-Machida, E.; Han, Y.; Guo, M.; Ames, S.; Glockner, S.; Piantadosi, S.; Gabrielson, E.; Pridham, G.; Pelosky, K.; Belinsky, S.A.; Yang, S.C.; Baylin, S.B.; Herman, J.G. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008 Mar 13;358(11):1118-1128.
Daniels, J.A.; Gibson, M.K.; Xu, L.; Sun, S.; Canto, M.I.; Heath, E.; Wang, J.; Brock, M.; Montgomery, E. Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect. Am J Surg Pathol. 2008 Mar;32(3):473-477.
Forastiere, A.A.; Ang, K.K.; Brizel, D.; Brockstein, B.E.; Burtness, B.A.; Cmelak, A.J.; Colevas, A.D.; Dunphy, F.; Eisele, D.W.; Goepfert, H.; Hicks, W.L., Jr.; Kies, M.S.; Lydiatt, W.M.; Maghami, E.; Martins, R.; McCaffrey, T.; Mittal, B.B.; Pfister, D.G.; Pinto, H.A.; Posner, M.R.; Ridge, J.A.; Samant, S.; Schuller, D.E.; Shah, J.P.; Spencer, S.; Trotti, A., 3rd; Weber, R.S.; Wolf, G.T.; Worden, F. Head and neck cancers. J Natl Compr Canc Netw. 2008 Aug;6(7):646-695.
Guo, M.; Ren, J.; Brock, M.V.; Herman, J.G.; Carraway, H.E. Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. Epigenetics. 2008 Nov;3(6):336-341.
Kleinberg, L.R.; Brock, M.V.; Jagannath, S.B.; Forastiere, A.A. Cancer of the Esophagus. In: Abeloff, M.e.a., editor. 4th Edition ed, Clinical Oncology. New York, NY: Churchill-Livingstone; 2008.
Meguid, R.A.; Brooke, B.S.; Chang, D.C.; Sherwood, J.T.; Brock, M.V.; Yang, S.C. Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg. 2008 Mar;85(3):1015-1024; discussion 1024-1015.
Argiris, A.; Buchanan, A.; Brockstein, B.; Kolesar, J.; Ghebremichael, M.; Pins, M.; Hahn, K.; Axelrod, R.; Forastiere, A. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Cancer. 2009 Oct 1;115(19):4504-4513.
Jiang, T.; Collins, B.J.; Jin, N.; Watkins, D.N.; Brock, M.V.; Matsui, W.; Nelkin, B.D.; Ball, D.W. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res. 2009 Feb 1;69(3):845-854.
Meguid, R.A.; Hooker, C.M.; Taylor, J.T.; Kleinberg, L.R.; Cattaneo, S.M., 2nd; Sussman, M.S.; Yang, S.C.; Heitmiller, R.F.; Forastiere, A.A.; Brock, M.V. Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg. 2009 Dec;138(6):1309-1317.
Meguid, R.A.; Weiss, E.S.; Chang, D.C.; Brock, M.V.; Yang, S.C. The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg. 2009 Jan;137(1):23-29.
Tjiang, T.; B.J., C.; Jin, N.; Brock, M.V.; Watkins, D.N.; Matsui, W.; Nelkin, B.D.; Ball, D.W. ASCL1 regulates CD133 and tumor-initiating capacity of SCLC. Cancer Research. 2009 (In Press).
Bailey, V.J.; Keeley, B.P.; Zhang, Y.; Ho, Y.P.; Easwaran, H.; Brock, M.V.; Pelosky, K.L.; Carraway, H.E.; Baylin, S.B.; Herman, J.G.; Wang, T.H. Enzymatic incorporation of multiple dyes for increased sensitivity in QD-FRET sensing for DNA methylation detection. Chembiochem. 2010 Jan 4;11(1):71-74.
Bailey, V.J.; Zhang, Y.; Keeley, B.P.; Yin, C.; Pelosky, K.L.; Brock, M.; Baylin, S.B.; Herman, J.G.; Wang, T.H. Single-tube analysis of DNA methylation with silica superparamagnetic beads. Clin Chem. 2010 Jun;56(6):1022-1025.
Bhattacharya, R.; Kowalski, J.; Larson, A.R.; Brock, M.; Alani, R.M. Id1 promotes tumor cell migration in nonsmall cell lung cancers. J Oncol. 2010;2010:856105.
Brock, M.V.; Bouvet, M. Writing a successful NIH Mentored Career Development Grant (K award): hints for the junior faculty surgeon. Ann Surg. 2010 Jun;251(6):1013-1017
Chiao, E.Y.; Dezube, B.J.; Krown, S.E.; Wachsman, W.; Brock, M.V.; Giordano, T.P.; Mitsuyasu, R.; Pantanowitz, L. Time for oncologists to opt in for routine opt-out HIV testing? JAMA. 2010 Jul 21;304(3):334-339
Liu, K.J.; Brock, M.V.; Shih Ie, M.; Wang, T.H. Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy. J Am Chem Soc. 2010 Apr 28;132(16):5793-5798
Meguid, R.A.; Hooker, C.M.; Harris, J.; Xu, L.; Westra, W.H.; Sherwood, J.T.; Sussman, M.; Cattaneo, S.M., 2nd; Shin, J.; Cox, S.; Christensen, J.; Prints, Y.; Yuan, N.; Zhang, J.; Yang, S.C.; Brock, M.V. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest. 2010 Sep;138(3):500-509.
Tseng, E.E.; Brock, M.V.; Lange, M.S.; Troncoso, J.C.; Blue, M.E.; Lowenstein, C.J.; Johnston, M.V.; Baumgartner, W.A. Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg. 2010 Feb;89(2):440-445
Research Interests
- Epigenetics research for cancer treatment
- Tumor Biology of Lung and Esophageal Cancer
- Biomarkers as predictors of cancer detection
- Prognosis and Chemotherapy Sensitivity
- Hyperhidrosis
- Translating Basic Research into the Clinic
More Info
Languages
- English
- Japanese
Additional Resources
The Sidney Kimmel Comprehensive Cancer Center
Department of Surgery
Esophageal Cancer Program
Lung Cancer Program
Department of Surgery
Esophageal Cancer Program
Lung Cancer Program
Videos and Podcasts
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts